Skip to main content

Table 1 Background characteristics of the patients (n = 64)

From: A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)

Gender, male (n)

52

Age, mean (± SD)

29.9 ± 7

Duration of heroin use (month) mean ± SDa

72.2 ± 94.2

Buprenorphine treatment (days) mean ± SD

63.3 ± 363

Subutex mean daily treatment dose (mg) ± SD

22.9 ± 5.4

  1. a59 patients reported history of heroin use